scholarly article | Q13442814 |
P356 | DOI | 10.1007/BF00543328 |
P698 | PubMed publication ID | 4007035 |
P2093 | author name string | A Darragh | |
A J Gordon | |||
E Casey | |||
D Hobbs | |||
H O'Byrne | |||
P2860 | cites work | Pharmacokinetics of ketoprofen in the elderly | Q34512945 |
Experience with piroxicam in general practice: results of a German multicenter study on 18,888 patients. | Q39560583 | ||
Clinical Pharmacokinetics of Non-steroidal Anti-inflammatory Drugs | Q40157661 | ||
Comparative pharmacokinetic changes and drug therapy in an older population. | Q40245100 | ||
Piroxicam: a review of its pharmacological properties and therapeutic efficacy | Q40311391 | ||
Assessment of nephrotoxicity | Q40325362 | ||
Drug therapy considerations in the elderly. | Q40326688 | ||
Drug therapy: drug disposition in old age. | Q40328549 | ||
Biological determinants of altered pharmacokinetics in the elderly | Q40332289 | ||
Pharmacokinetic observations on piroxicam in young adult, middle-aged and elderly patients | Q43261977 | ||
Effect of Age and Sex on Human Drug Metabolism | Q50348052 | ||
Pharmacokinetic studies of benoxaprofen in geriatric patients. | Q51652496 | ||
Treatment of osteoarthritis with piroxicam | Q70262487 | ||
Pharmacokinetic profile of benoxaprofen in subjects with normal and impaired renal function, prediction of multiple-dose kinetics | Q70369707 | ||
The pharmacokinetics of benoxaprofen in elderly subjects | Q70369735 | ||
Adverse drug effects in the elderly patient | Q70381113 | ||
Drugs in the elderly | Q70489039 | ||
Analysis of piroxicam in plasma by high-performance liquid chromatography | Q71269589 | ||
Pharmacokinetics of piroxicam in man | Q71763042 | ||
Non-steroidal anti-inflammatory drugs: have we been spoilt for choice? | Q72569592 | ||
P433 | issue | 3 | |
P921 | main subject | pharmacokinetics | Q323936 |
P304 | page(s) | 305-309 | |
P577 | publication date | 1985-01-01 | |
P1433 | published in | European Journal of Clinical Pharmacology | Q1376707 |
P1476 | title | Single-dose and steady-state pharmacokinetics of piroxicam in elderly vs young adults | |
P478 | volume | 28 |
Q42216963 | A double-blind multicentre trial of piroxicam and naproxen in osteoarthritis |
Q51050937 | Are systemic levels of non steroidal anti inflammatory drugs relevant to acute upper gastrointestinal haemorrhage? |
Q38018026 | Hepatic drug metabolism and aging |
Q68506534 | Nonsteroidal anti-inflammatory drugs |
Q37724345 | Pharmacokinetics of newer drugs in patients with renal impairment (Part I). |
Q34339828 | Pharmacokinetics of oxicam nonsteroidal anti-inflammatory agents |
Q69021354 | Piroxicam and 5'-hydroxypiroxicam kinetics following multiple dose administration of piroxicam |
Q68915989 | Piroxicam and naproxen plasma concentrations in patients with osteoarthritis: relation to age, sex, efficacy and adverse events |
Q28191840 | Risks and benefits of nonsteroidal anti-inflammatory drugs in children: a comparison with paracetamol |
Q51655106 | Steady state pharmacokinetics of piroxicam in children with rheumatic diseases |
Q72674430 | The consequences of H2 receptor antagonist--piroxicam coadministration in patients with joint disorders |
Q34345908 | The pharmacokinetics of piroxicam in elderly persons with and without renal impairment |
Q41526041 | Toxicity of Nonsteroidal Anti-Inflammatory Drugs in the Elderly: Is Advanced Age a Risk Factor? |
Q42658549 | Transsynovial kinetics of piroxicam in patients with rheumatoid arthritis |
Search more.